CN101757340A - Traditional Chinese medicine for treating scrofula - Google Patents

Traditional Chinese medicine for treating scrofula Download PDF

Info

Publication number
CN101757340A
CN101757340A CN200810157954A CN200810157954A CN101757340A CN 101757340 A CN101757340 A CN 101757340A CN 200810157954 A CN200810157954 A CN 200810157954A CN 200810157954 A CN200810157954 A CN 200810157954A CN 101757340 A CN101757340 A CN 101757340A
Authority
CN
China
Prior art keywords
parts
chinese medicine
fructus
traditional chinese
treating
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN200810157954A
Other languages
Chinese (zh)
Inventor
刘新光
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to CN200810157954A priority Critical patent/CN101757340A/en
Publication of CN101757340A publication Critical patent/CN101757340A/en
Pending legal-status Critical Current

Links

Landscapes

  • Medicines Containing Plant Substances (AREA)

Abstract

The invention relates to a traditional Chinese medicine for treating scrofula, which comprises the Chinese medicinal herbs in parts by weight: 3-5 parts of dragon's blood, 4-6 parts of frankincense, 3-5 parts of myrrh, 5-8 parts of astragalus mongholicus, 5-8 parts of dried orange peel, 4-6 parts of houttuynia cordata, 7-10 parts of honeysuckle, 7-10 parts of fructus forsythia, 3-5 parts of schizonepeta, 4-6 parts of burdock and 3-5 parts of platycodon grandiflorum. The traditional Chinese medicine is prepared into a clinically acceptable excipient by treating the Chinese medicinal herbs by using different physical or chemical methods according to different physical and chemical characteristics of effective components of the Chinese medicinal herbs. The invention which is a traditional Chinese medicine preparation has special formula, high pain-easing and inflammation-diminishing speed, good treatment effect, high cure rate, no side effects, low recurrence rate, simple application and preparation method and low production cost. The invention is clinically used for treating the rheumatoid arthritis with remarkable effect.

Description

The scrofulous Chinese medicine of a kind of treatment
Technical field:
The present invention relates to the scrofulous Chinese medicine of a kind of treatment.
Background technology:
A few days ago, the scrofulous medicine of state's internal therapy is a lot, but in Chinese medicine, the Chinese medicine that the treatment works well seldom can not reach the therapeutic effect that treatment combines with functional rehabilitation.The present invention wishes to find the reasonable medicine in a kind of treatment scrofulous Chinese medicine aspect.
Summary of the invention:
The objective of the invention is invention and the purpose of this invention is to provide the scrofulous Chinese medicine of a kind of treatment, and easy to use, can reach the therapeutic effect that treatment combines with functional rehabilitation.Technical solution of the present invention is achieved in that by Sanguis Draxonis, Olibanum, Myrrha, the Radix Astragali, Pericarpium Citri Reticulatae, Herba Houttuyniae, Flos Lonicerae, Fructus Forsythiae, Herba Schizonepetae, Fructus Arctii, Radix Platycodonis to be formed, the wherein wt ratio is 3~5 parts of Sanguis Draxonis, 4~6 parts of Olibanums, 3~5 parts of Myrrhas, 5~8 parts of the Radixs Astragali, 5~8 parts of Pericarpium Citri Reticulataes, 4~6 parts of Herba Houttuyniae, 7~10 parts of Flos Loniceraes, 7~10 parts of Fructus Forsythiaes, 3~5 parts of Herba Schizonepetae, 4~6 parts of Fructus Arctiis, 3~5 parts of Radix Platycodoniss.According to the different physicochemical properties of every flavor Chinese medicine effect components, be prepared from the clinical dosage form of accepting after handling with different physics or chemical method respectively.The Sanguis Draxonis promoting blood circulation to remove blood stasis, analgesic therapy, hemostasia and promoting granulation is held back skin ulcer; The Olibanum regulating QI is invigorated blood circulation, and pain relieving chases after poison; The Myrrha blood blood stasis removing that looses, subduing swelling and relieving pain; Radix Astragali slightly warm in nature, sweet in the mouth has the effect of invigorating QI to consolidate the body surface resistance, hidroschesis detoxification, granulation promoting, diuresis, detumescent; The Pericarpium Citri Reticulatae regulating qi-flowing for strengthening spleen, drying dampness to eliminate phlegm; The Herba Houttuyniae heat-clearing and toxic substances removing, eliminating carbuncle evacuation of pus, inducing diuresis for treating stranguria syndrome; The Flos Lonicerae heat-clearing and toxic substances removing, dispelling wind and heat pathogens; The Fructus Forsythiae heat-clearing and toxic substances removing, dispersing swelling and dissipating binds; The Herba Schizonepetae diffusing wind that induces sweat, rash, the skin ulcer that disappears, hemostasis; The Fructus Arctii dispelling wind and heat pathogens, lung qi dispersing rash, resolving toxin and disinhibiting the throat; The Radix Platycodonis lung qi dispersing; Eliminate the phlegm; Sore-throat relieving; Evacuation of pus.
The object of the present invention is achieved like this: the weight proportion of each component described in the scrofulous Chinese medicine of treatment of the present invention is 3~5 parts of Sanguis Draxonis, 4~6 parts of Olibanums, 3~5 parts of Myrrhas, 5~8 parts of the Radixs Astragali, 5~8 parts of Pericarpium Citri Reticulataes, 4~6 parts of Herba Houttuyniae, 7~10 parts of Flos Loniceraes, 7~10 parts of Fructus Forsythiaes, 3~5 parts of Herba Schizonepetae, 4~6 parts of Fructus Arctiis, 3~5 parts of Radix Platycodoniss.The optimum weight proportioning of described each component is 3 parts of Sanguis Draxonis, 4 parts of Olibanums, 3 parts of Myrrhas, 6 parts of the Radixs Astragali, 6 parts of Pericarpium Citri Reticulataes, 4 parts of Herba Houttuyniae, 8 parts of Flos Loniceraes, 8 parts of Fructus Forsythiaes, 4 parts of Herba Schizonepetae, 6 parts of Fructus Arctiis, 4 parts of Radix Platycodoniss.
Sanguis Draxonis 15g, Olibanum 20g, Myrrha 15g, Radix Astragali 30g, Pericarpium Citri Reticulatae 30g, Herba Houttuyniae 20g, Flos Lonicerae 40g, Fructus Forsythiae 40g, Herba Schizonepetae 20g, Fructus Arctii 30g, Radix Platycodonis 20g, this is a dosage.
During use, with Sanguis Draxonis 15g, Olibanum 20g, Myrrha 15g, Radix Astragali 30g, Pericarpium Citri Reticulatae 30g, Herba Houttuyniae 20g, Flos Lonicerae 40g, Fructus Forsythiae 40g, Herba Schizonepetae 20g, Fructus Arctii 30g, Radix Platycodonis 20g, this is a dosage, adds the 500g decocting and obeys to 150g, and 1 dose in every order divides and takes for 3 times, can effectively treat lymphoid tuberculosis.
The invention has the beneficial effects as follows: raw material is simple, with being decocted in water for oral dose, divides clothes 3 times 1 dose of every day, can effectively treat lymphoid tuberculosis.
Specific embodiment:
1, with Sanguis Draxonis 15g, Olibanum 20g, Myrrha 15g, Radix Astragali 30g, Pericarpium Citri Reticulatae 30g, Herba Houttuyniae 20g, Flos Lonicerae 40g, Fructus Forsythiae 40g, Herba Schizonepetae 20g, Fructus Arctii 30g, Radix Platycodonis 20g, this is a dosage, adds the 500g decocting and obeys to 150g, divides and takes for 3 times 1 dose of every day, can effectively treat lymphoid tuberculosis.Continuous 18 days, lymph node inflammation transference cure did not have recurrence in 1 year.
2, with Sanguis Draxonis 18g, Olibanum 24g, Myrrha 18g, Radix Astragali 36g, Pericarpium Citri Reticulatae 36g, Herba Houttuyniae 24g, Flos Lonicerae 48g, Fructus Forsythiae 48g, Herba Schizonepetae 24g, Fructus Arctii 26g, Radix Platycodonis 24g, this is a dosage, adds the 500g decocting and obeys to 150g, 1 dose of every day, divide and take for 3 times, after continuous 6 days, the lymph node pain symptom disappears, and continues to take the lymphoid tuberculosis transference cure 12.

Claims (3)

1. treat scrofulous Chinese medicine for one kind, it is characterized in that: be made up of Sanguis Draxonis, Olibanum, Myrrha, the Radix Astragali, Pericarpium Citri Reticulatae, Herba Houttuyniae, Flos Lonicerae, Fructus Forsythiae, Herba Schizonepetae, Fructus Arctii, Radix Platycodonis, the wherein wt ratio is 3~5 parts of Sanguis Draxonis, 4~6 parts of Olibanums, 3~5 parts of Myrrhas, 5~8 parts of the Radixs Astragali, 5~8 parts of Pericarpium Citri Reticulataes, 4~6 parts of Herba Houttuyniae, 7~10 parts of Flos Loniceraes, 7~10 parts of Fructus Forsythiaes, 3~5 parts of Herba Schizonepetae, 4~6 parts of Fructus Arctiis, 3~5 parts of Radix Platycodoniss.
2. according to the scrofulous Chinese medicine of the described a kind of treatment of claim 1, it is characterized in that: the optimum weight proportioning of each component is 3 parts of Sanguis Draxonis, 4 parts of Olibanums, 3 parts of Myrrhas, 6 parts of the Radixs Astragali, 6 parts of Pericarpium Citri Reticulataes, 4 parts of Herba Houttuyniae, 8 parts of Flos Loniceraes, 8 parts of Fructus Forsythiaes, 4 parts of Herba Schizonepetae, 6 parts of Fructus Arctiis, 4 parts of Radix Platycodoniss.
3. according to the scrofulous Chinese medicine of the described a kind of treatment of claim 1, it is characterized in that:, be prepared from the clinical dosage form of accepting after handling with different physics or chemical method respectively according to the different physicochemical properties of every flavor Chinese medicine effect components.
CN200810157954A 2008-10-20 2008-10-20 Traditional Chinese medicine for treating scrofula Pending CN101757340A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN200810157954A CN101757340A (en) 2008-10-20 2008-10-20 Traditional Chinese medicine for treating scrofula

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN200810157954A CN101757340A (en) 2008-10-20 2008-10-20 Traditional Chinese medicine for treating scrofula

Publications (1)

Publication Number Publication Date
CN101757340A true CN101757340A (en) 2010-06-30

Family

ID=42488824

Family Applications (1)

Application Number Title Priority Date Filing Date
CN200810157954A Pending CN101757340A (en) 2008-10-20 2008-10-20 Traditional Chinese medicine for treating scrofula

Country Status (1)

Country Link
CN (1) CN101757340A (en)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102579774A (en) * 2012-03-13 2012-07-18 李永泉 Traditional Chinese medicine composition for treating tuberculosis of cervical lymph nodes
CN108392537A (en) * 2018-06-05 2018-08-14 卢光明 For treating scrofulous Chinese medicine

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102579774A (en) * 2012-03-13 2012-07-18 李永泉 Traditional Chinese medicine composition for treating tuberculosis of cervical lymph nodes
CN108392537A (en) * 2018-06-05 2018-08-14 卢光明 For treating scrofulous Chinese medicine

Similar Documents

Publication Publication Date Title
CN1698745B (en) Externally applied anti-inflammation Chinese medicine composition
CN104606479A (en) Traditional Chinese medicine composition for treating hemorrhoids
CN103041149A (en) Traditional Chinese medicine formula for treating chronic pharyngolaryngitis
CN103656042A (en) Medicine for treating herpes zoster
CN104173440A (en) Traditional Chinese medicine for treating cerebral thrombus
CN101757340A (en) Traditional Chinese medicine for treating scrofula
CN102784352A (en) Agent for treating psoriasis vulgaris
CN104352933A (en) Wind-dispelling and dampness-eliminating traditional Chinese medicine containing golden buckwheat rhizomes
CN105616643A (en) Traditional Chinese medicinal treatment liquid for treating erosive psoriasis
CN101991696A (en) Chinese material medical preparation for treating urticaria
CN102772524A (en) Acupuncture point application patch for treating urticaria
CN103120752A (en) Chinese medicinal composition for treating oral ulcer
CN101953943A (en) Traditional Chinese medicine for treating chronic aplastic anemia
CN101279053B (en) Chinese medicine for curing paint dermatitis
CN102038906A (en) Medicament for treating psoriasis
CN102018811A (en) Chinese materia medica preparation for treating urticaria
CN102038928A (en) Traditional Chinese medicine for treating acute and chronic urticaria and dermatosis
CN103989953A (en) Traditional Chinese medicinal composition for treating infantile paralysis
CN104623278A (en) External traditional Chinese medicine for treating heat toxin type acne
CN103845402A (en) Traditional Chinese medicine for treating acute mastitis
CN105708943A (en) Traditional Chinese medicine treatment liquid for treating rash-type psoriasis
CN104383063A (en) Traditional Chinese medicine for treating dental ulcer
CN103933139A (en) Traditional Chinese medicinal preparation for effectively treating flat wart
CN104173614A (en) Traditional Chinese medicine for treating chronic gastricism
CN104161782A (en) Traditional Chinese medicine for treating taeniasissuis

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
DD01 Delivery of document by public notice

Addressee: Liu Xinguang

Document name: Notification of Publication and of Entering the Substantive Examination Stage of the Application for Invention

DD01 Delivery of document by public notice

Addressee: Liu Xinguang

Document name: the First Notification of an Office Action

DD01 Delivery of document by public notice

Addressee: Liu Xinguang

Document name: Notification that Application Deemed to be Withdrawn

C02 Deemed withdrawal of patent application after publication (patent law 2001)
WD01 Invention patent application deemed withdrawn after publication

Open date: 20100630